Dapagliflozin improves outcomes in HFmrEF and HFpEF

被引：0
|
作者：
Fernandez-Ruiz, Irene
机构：
[1] Nature Reviews Cardiology,
来源：
NATURE REVIEWS CARDIOLOGY | 2022年 / 19卷 / 11期
关键词：
D O I：
10.1038/s41569-022-00782-x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In patients with heart failure (HF) with mildly reduced or preserved ejection fraction, the SGLT2 inhibitor dapagliflozin reduces the risk of worsening HF or cardiovascular death by 18%, reduces total HF events and cardiovascular deaths by 23% and improves HF symptoms, according to findings from the DELIVER trial.
引用
收藏
页码：719 / 719
页数：1
相关论文
共 50 条
  • [1] Dapagliflozin improves outcomes in HFmrEF and HFpEF
    Irene Fernández-Ruiz
    Nature Reviews Cardiology, 2022, 19 : 719 - 719
  • [2] Finerenone improves outcomes in HFmrEF and HFpEF
    Fernandez-Ruiz, Irene
    NATURE REVIEWS CARDIOLOGY, 2024, 21 (11) : 739 - 739
  • [3] How to Measure DELIVERed Benefits of Dapagliflozin in the Management of HFmrEF/HFpEF?
    Tanaka, Atsushi
    Sawami, Kosuke
    Node, Koichi
    JACC-HEART FAILURE, 2023, 11 (02) : 261 - 261
  • [4] Dapagliflozin improves exercise capacity in HFpEF
    Lim G.B.
    Nature Reviews Cardiology, 2022, 19 (1) : 6 - 6
  • [5] Blood Pressure and Lack of Association With Treatment Benefits of Dapagliflozin in HFpEF and HFmrEF Reply
    Selvaraj, Senthil
    Solomon, Scott D.
    JACC-HEART FAILURE, 2023, 11 (02) : 261 - 261
  • [6] Efficacy and safety of dapagliflozin in the background of polypharmacy among patients with HFmrEF and HFpEF in the DELIVER trial
    Peikert
    Goyal, P.
    Vaduganathan, M.
    Claggett, B. L.
    Desai, A. S.
    Jhund, P. S.
    Kosiborod, M. N.
    Lam, C. S. P.
    Inzucchi, S. E.
    A Martinez, F.
    De Boer, R. A.
    Hernandez, A. F.
    Shah, S. J.
    Mcmurray, J. J. V.
    Solomon, S. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 196 - 197
  • [7] Mechanisms and outcomes of heart failure: from HFpEF, HFmrEF, and HFrEF to transplantation
    Luescher, Thomas F.
    EUROPEAN HEART JOURNAL, 2018, 39 (20) : 1749 - 1753
  • [8] Similarities and Differences Between HFmrEF and HFpEF
    Li, Peixin
    Zhao, Hengli
    Zhang, Jianyu
    Ning, Yunshan
    Tu, Yan
    Xu, Dingli
    Zeng, Qingchun
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [9] Outcomes of KDIGO-Defined CKD in US Veterans With HFpEF, HFmrEF, and HFrEF
    Patel, Samir
    Raman, Venkatesh K.
    Faselis, Charles
    Fonarow, Gregg C.
    Lam, Phillip H.
    Ahmed, Amiya A.
    Heidenreich, Paul A.
    Anker, Stefan D.
    Deedwania, Prakash
    Morgan, Charity J.
    Zhang, Sijian
    Moore, Hans
    Rangaswami, Janani
    Bakris, George
    Butler, Javed
    Sheriff, Helen M.
    Allman, Richard M.
    Zeng-Treitler, Qing
    Wu, Wen-Chih
    Ahmed, Ali
    JACC-HEART FAILURE, 2025, 13 (03) : 467 - 479
  • [10] Left atrial strain parameters predict clinical outcomes in patients with HFmrEF and HFpEF
    Vrettos, A.
    Al Saikhan, L.
    Matiti, L.
    Plymen, C.
    Low, B.
    Nihoyannopoulos, P.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1423 - 1423
12345